Skip to main content

Table 2 Age stratified distribution of ASCVD risk scores in FM cases and healthy controls

From: Cardiovascular risk assessment using ASCVD risk score in fibromyalgia: a single-centre, retrospective study using “traditional” case control methodology and “novel” machine learning

Age (in years)

ASCVD risk score

10-year risk

Lifetime risk

 < 7.5% (low)

 ≥ 7.5% (high)

OR

p-value

 < 39% (low)

 ≥ 39% (high)

OR

p-value

(CI)

(CI)

18–39 years

        

 FM cases (n = 29)

 

19

10

0.649

0.267

 Healthy controls (n = 428)

 

235

193

(0.29–1.41)

 

40–59 years

        

 FM cases (n = 97)

92

5

2.27

0.093

62

35

1.56

0.044

 Healthy Control (n = 1071)

1046

25

(0.85–6.08)

 

787

284

(1.01–2.42)

 

 ≥ 60 years

        

 FM cases (n = 13)

8

5

0.56

0.307

 Healthy control (n = 321)

151

170

(0.18–1.73)

 

  1. FM, fibromyalgia; ASCVD, Atherosclerotic cardiovascular disease; OR, odd’s ratio; CI, 95% confidence interval; Emboldened summary estimate is statistically significant at p < 0.05.
  2. 10-year ASCVD risk calculated only for patients 40 years and more; Lifetime ASCVD risk calculated for patients who are less than 60 years of age